asenapine transdermal Secuado
Selected indexed studies
- Transdermal Asenapine in Schizophrenia: A Systematic Review. (Patient Prefer Adherence, 2020) [PMID:32943849]
- Asenapine Transdermal Patch for the Management of Schizophrenia. (Psychopharmacol Bull, 2020) [PMID:33012873]
- New Agents in the Treatment of Psychiatric Disorders: What Innovations and in What Areas of Psychopathology? (Pharmaceuticals (Basel), 2025) [PMID:40430486]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Transdermal Asenapine in Schizophrenia: A Systematic Review. (2020) pubmed
- Asenapine: an atypical antipsychotic with atypical formulations. (2021) pubmed
- Asenapine Transdermal Patch for the Management of Schizophrenia. (2020) pubmed
- New Agents in the Treatment of Psychiatric Disorders: What Innovations and in What Areas of Psychopathology? (2025) pubmed
- In brief: An asenapine patch (Secuado) for schizophrenia. (2021) pubmed
- Pharmacokinetic Profile of the Asenapine Transdermal System (HP-3070). (2021) pubmed
- Boosting the In Vivo Transdermal Bioavailability of Asenapine Maleate Using Novel Lavender Oil-Based Lipid Nanocapsules for Management of Schizophrenia. (2023) pubmed
- Efficacy of HP-3070, an Asenapine Transdermal System, on Symptoms of Hostility in Adults With Schizophrenia: A Post Hoc Analysis of a 6-Week Phase 3 Study. (2022) pubmed
- New Antipsychotic Medications in the Last Decade. (2021) pubmed
- Transdermal Delivery of Antipsychotics: Rationale and Current Status. (2019) pubmed